LifeVantage Announces Launch Date for the Netherlands
May 27 2016 - 1:15PM
LifeVantage Corporation (Nasdaq:LFVN), has announced its continued
expansion into the European Union, and will officially begin sales
activities in the Netherlands on June 1, 2016.
According to the World Federation of Direct Selling Associations
(WFDSA), the European Union represented nearly $33 billion in
retail sales in 2014.
“I see the Netherlands as one of the ideal gateway markets for
entry into continental Europe,” said LifeVantage President and
Chief Executive Officer, Darren Jensen. “The Netherlands is ideally
situated geographically to serve as our base of operations in
Europe. The European market as a whole is in alignment with our
culture at LifeVantage because they are a brand and product focused
area with loyal customers and incredible field leadership.”
About LifeVantage Corporation LifeVantage
Corporation (Nasdaq:LFVN), is a science based network marketing
company dedicated to visionary science that looks to transform
health, wellness and anti-aging internally and externally at the
cellular level. The company is the maker of Protandim®, the Nrf2
Synergizer® patented dietary supplement, the TrueScience™
Anti-Aging Skin Care Regimen, Canine Health, the AXIO™ energy
product line and the PhysIQ™ smart weight management system.
LifeVantage was founded in 2003 and is headquartered in Salt Lake
City, Utah.
Forward Looking StatementsThis document
contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Words and expressions reflecting optimism, satisfaction or
disappointment with current prospects, as well as words such as
"believe", "hopes", "intends", "estimates", "expects", "projects",
"plans", "anticipates", "look forward to", “goal”, “ideal fit”, and
variations thereof, identify forward-looking statements, but their
absence does not mean that a statement is not forward-looking.
Examples of forward-looking statements include, but are not limited
to, statements we make regarding our leadership in the global
market, future growth and financial performance. Such
forward-looking statements are not guarantees of performance and
the Company's actual results could differ materially from those
contained in such statements. These forward-looking statements are
based on the Company's current expectations and beliefs concerning
future events affecting the Company and involve known and unknown
risks and uncertainties that may cause the Company's actual results
or outcomes to be materially different from those anticipated and
discussed herein. These risks and uncertainties include, among
others, those discussed in greater detail in the Company's Annual
Report on Form 10-K and the Company's Quarterly Report on Form 10-Q
under the caption "Risk Factors," and in other documents filed by
the Company from time to time with the Securities and Exchange
Commission. The Company cautions investors not to place undue
reliance on the forward-looking statements contained in this
document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the
Company undertakes no obligation to revise or update these
forward-looking statements to reflect events or circumstances after
the date of this document, except as required by law.
Company Relations Contact:
John Genna (801) 432-9172
Vice President of Communications
& Corporate Partnerships
Investor Relations Contact:
Cindy England (801) 432-9036
Director of Investor Relations
-or-
Scott Van Winkle (617) 956-6736
Managing Director, ICR INC
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2024 to May 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From May 2023 to May 2024